Skip to content

Randomized controlled clinical study of Guluo Tong treatment of primary osteoporosis

Randomized controlled clinical study of Guluo Tong treatment of primary osteoporosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000897
Enrollment
Unknown
Registered
2024-12-30
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary osteoporosis

Interventions

experimental group:Calcium carbonate vitamin D3+ Guluotong capsule
Control Group:Calcium carbonate vitamin D3

Sponsors

Affiliated Hospital of Shaanxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for primary osteoporosis; (2) In line with osteoporosis spleen kidney Yang deficiency syndrome; (3) 45= age =75 gender is not limited; (4) Those who agree to participate in the study and sign the informed consent;

Exclusion criteria

Exclusion criteria: (1) Suffering from secondary osteoporosis suffering from serious cardiovascular and cerebrovascular diseases malignant tumors hematopoietic system and other diseases. (2) Abnormal liver and kidney function allergic to the drug; (3) Fractures within the last 3 months fractures requiring surgical treatment; (4) Anti-osteoporosis drugs were used within the last 3 months; (5) Spinal and double hip malformations affecting bone densitometry; (6) severe gastrointestinal absorption dysfunction swallowing difficulties such as esophagitis enteritis or digestive ulcer;

Design outcomes

Primary

MeasureTime frame
Bone mineral density;

Secondary

MeasureTime frame
TCM syndrome integral;muscle mass;Pain VAS score;ECOS-16 Quality of Life Questionnaire;Type I collagen cross-linked C-terminal peptide;Electrolytes (Ca P);

Countries

Chinese

Contacts

Public ContactWenxiong Li

Shaanxi University of Chinese Medicine

liwenxiong55@163.com15706016769

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026